Journal of Neurology

, Volume 239, Issue 8, pp 417–425 | Cite as

Hallervorden-Spatz disease: clinical and MRI study of 11 cases diagnosed in life

  • L. Angelini
  • N. Nardocci
  • V. Rumi
  • C. Zorzi
  • L. Strada
  • M. Savoiardo
Original Communications


The diagnosis of Hallervorden-Spatz disease (HSD) has usually been made post mortem, although the recent description of characteristic abnormalities in the globus pallidus has suggested the possibility of an in vivo diagnosis. We present the clinical histories, neurological features and MRI findings of 11 patients, diagnosed as having HSD. Generalized dystonia with pre dominance of oromandibular involvement, behavioural changes followed by dementia and retinal degeneration were present in all the patients. MRI pallidal abnormalities consisted of decreased signal intensity in T2-weighted images, compatible with iron deposits, and of a small area of hyperintensity in its internal segment (“eye of the tiger” sign). We propose that the combination of these neurological signs with these MRI findings could be considered as highly suggestive of a diagnosis of HSD in living patients.

Key words

Hallervorden-Spatz disease Progressive dystonia Magnetic resonance imaging Child neurology 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Angelini L, Rumi V, Nardocci N (1987) Idiopathic and symptomatic dystonia. In: Angelini L, Lanzi G, Balottin U, Nardocci N (eds) Extrapyramidal disorders in childhood. Elsevier, Amsterdam, pp 65–80Google Scholar
  2. 2.
    Angelini L, Nardocci N, Rumi V, Lamperti E (1989) Idiopathic dystonia with onset in childhood. J Neurol 236:319–321Google Scholar
  3. 3.
    Benson DF (1984) Parkinson dementia: cortical or sub-cortical? In: Hassler RG, Christ JF (eds) Advances in neurology, vol 40. Raven Press, New York, pp 235–240Google Scholar
  4. 4.
    Berkovic SF, Karpati G, Carpenter S, Lang AE (1987) Progressive dystonia with bilateral putaminal hypodensities. Arch Neurol 44:1184–1187Google Scholar
  5. 5.
    Boltshauser E, Lang W, Janzer R, et al (1987) Computed tomography in Hallervorden-Spatz disease. Neuropediatrics 18:81–83Google Scholar
  6. 6.
    Brown RG, Marsden CD (1988) “Subcortical dementia”: the neuropsychological evidence. Neuroscience 25:363–387Google Scholar
  7. 7.
    Defendini R, Markesbery WR, Mastry AR, Duffy PE (1973) Hallervorden-Spatz disease and infantile neuroaxonal dystrophy. Ultrastructural observations, anatomical pathology and nosology. J Neurol Sci 20:7–23Google Scholar
  8. 8.
    Dooling EC, Schoene WC, Richardson EP Jr (1974) Hallervorden-Spatz syndrome. Arch Neurol 30:70–83Google Scholar
  9. 9.
    Dooling EC, Richardson EP Jr, Davis KR (1980) Computed tomography in Hallervorden-Spatz disease. Neurology 30: 1128–1130Google Scholar
  10. 10.
    Drayer B, Olanow W, Burger P, Johnson GA, Herfkens R, Riederer S (1986) Parkinson plus syndrome: diagnosis using high field MR imaging of brain iron. Radiology 159:493–498Google Scholar
  11. 11.
    Elejalde BR, De Elejalde MMJ, Lopez F (1979) Hallervorden-Spatz disease. Clin Genet 16:1–18Google Scholar
  12. 12.
    Fadiloglu S (1971) Early infantile familial forms of pigmentary pallido-reticular atrophy. Critical study of the value of the histopathological criteria in the differentiation of an infantile form of Hallervorden-Spatz disease. Acta Neurol Belg 71:392–406Google Scholar
  13. 13.
    Fahn S, Marsden CD, Calne DB (1987) Classification and investigation of dystonia. In: Marsden CD, Fahn S (eds) Movement disorders, 2. Butterworth, London, pp 332–358Google Scholar
  14. 14.
    Gallucci M, Cardona F, Arachi M, Splendiani A, Bozzo A, Passariello R (1989) Follow-up MR studies in Hallervorden-Spatz disease. J Comput Assist Tomogr 14:118–120Google Scholar
  15. 15.
    Goldman JE, Katz D, Rapin I, et al (1981) Chronic GM1-gangliosidosis presenting as dystonia. I. Clinical and pathological features. Ann Neurol 9:465–475Google Scholar
  16. 16.
    Hallervorden J, Spatz H (1922) Eigenartige Erkrankung im extrapyramidalen System mit besonderer Beteiligung des Globus Pallidus und der Substantia Nigra. J Neurol Psychiatr 79:254–302Google Scholar
  17. 17.
    Johnson MA, Pennock JM, Bydder GM, et al (1983) Clinical and MR imaging of the brain in children: normal and neurologic disease. Am J Roentgenol 141:1005–1018Google Scholar
  18. 18.
    Lang AE, Clarke JTR, Resch L, et al (1985) Progressive longstanding “pure” dystonia: a new phenotype of juvenile metachromatic leukodystrophy (MLD). Neurology 35 [Suppl 1]:194Google Scholar
  19. 19.
    Littrup PJ, Gebarski SS (1985) MR imaging of Hallervorden-Spatz disease. J Comput Assist Tomogr 9:491–493Google Scholar
  20. 20.
    Luckenbach MW, Green WR, Miller NR, et al (1983) Ocular clinicopathologic correlation of Hallervorden-Spatz syndrome with acanthocytosis and pigmentary retinopathy. Am J Ophthalmol 95:369–382Google Scholar
  21. 21.
    Malstrom-Groth AG, Kristensson K (1982) Neuroaxonal dystrophy in childhood. Report of two second cousins with Hallervorden-Spatz disease, and a case of Seitelberger's disease. Acta Paediat Scand 71:1045–1049Google Scholar
  22. 22.
    Meek D, Wolfe LS, Andermann E, Andermann F (1984) Juvenile progressive dystonia: a new phenotype of GM2-gangliosidosis. Ann Neurol 15:348–352Google Scholar
  23. 23.
    Nakano T, Ikeda SI, Kondo K, et al (1985) Adult GM1-gangliosidosis: clinical patterns and rectal biopsy. Neurology 35:875–880Google Scholar
  24. 24.
    Netsky MG, Zimmermann HM (1951) Hallervorden-Spatz disease and dystonia. J Neuropathol Exp Neurol 10:125–141Google Scholar
  25. 25.
    Newell FW, Johnson RO, Huttenlocher PR (1979) Pigmentary degeneration of the retina in the Hallervorden-Spatz syndrome. Am J Ophthalmol 88:467–471Google Scholar
  26. 26.
    Pastakia B, Polinsky R, Di Chiro G, Simmons JT, Brown R, Wener L (1986) Multiple system atrophy (Shy-Drager syndrome): MR imaging. Radiology 159:499–502Google Scholar
  27. 27.
    Perry TL, Norman MG, Yong VW, et al (1985) Hallervorden-Spatz disease: cysteine accumulation and cysteine dioxygenase deficiency in the globus pallidus. Ann Neurol 18:482–489Google Scholar
  28. 28.
    Roth AM, Hepler RS, Mukoyama M, et al (1971) Pigmentary retinal dystrophy in Hallervorden-Spatz disease: clinico-pathological report of a case. Surv Ophthalmol 16:24–35Google Scholar
  29. 29.
    Rutledge JN, Hilar SK, Silver AJ, et al (1987) Study of movement disorder and brain iron by magnetic resonance. Am J Neuroradiol 8:397–412Google Scholar
  30. 30.
    Savoiardo M, Strada L, Girotti F, D'Incerti L, Sberna M, Soliveri P, Balzarini L (1989) MR imaging in progressive supranuclear palsy and Shy-Drager syndrome. J Comput Assist Tomogr 13:555–560Google Scholar
  31. 31.
    Savoiardo M, Strada L, Girotti F, Zimmerman RA, Grisoli M, Testa D, Petrillo R (1990) Olivopontocerebellar atrophy: MR diagnosis and relationship to multisystem atrophy. Radiology 174:693–696Google Scholar
  32. 32.
    Schaffert DA, Johnsen SD, Johnson PC, Drayer BP (1989) Magnetic resonance imaging in pathologically proven Hallervorden-Spatz disease. Neurology 39:440–442Google Scholar
  33. 33.
    Seitelberg F (1986) Neuroaxonal dystrophy: its relation to aging and neurological diseases. In: Vinken PJ, Bruyn GW, Klawans HL (eds) Handbook of clinical neurology, vol 49. Elsevier, New York, pp 391–413Google Scholar
  34. 34.
    Seitelberger F, Jellinger K (1977) Neuroaxonal dystrophy and Hallervorden-Spatz disease. In: Goldensohn ES, Appel SM (eds) Scientific approaches to clinical neurology II. Lea & Febiger, Philadelphia, pp 1052–1072Google Scholar
  35. 35.
    Sethy KD, Adams RJ, Loring DW, El Gammal T (1988) Hallervorden-Spatz syndrome: clinical and magnetic resonance imaging correlations. Ann Neurol 24:692–694Google Scholar
  36. 36.
    Specola N, Vanier MT, Goutieres F, et al (1990) The juvenile and chronic forms of GM2-gangliosidosis: clinical and enzymatic heterogeneity. Neurology 40:145–150Google Scholar
  37. 37.
    Swaiman KF, Smith SA, Trock GL, Siddiqui AR (1983) Sea blue histiocytes, lymphocytic cytosomes, movement disorders and59Fe uptake in basal ganglia: Hallervorden-Spatz disease or ceroid storage disease with abnormal isotope scan? Neurology 33:301–305Google Scholar
  38. 38.
    Swick HM (1989) Diseases of gray matter. In: Swaiman KF (ed) Pediatric neurology. Principles and practice. Mosby, St Louis, pp 777–781Google Scholar
  39. 39.
    Swisher CN, Menkes JM, Cancilla PA, Dodge PR (1972) Coexistence of Hallervorden-Spatz disease with acanthocytosis. Trans Am Neurol Assoc 97:212–216Google Scholar
  40. 40.
    Tanfani G, Mascalchi M, Dal Pozzo GC, Taverni N, Saia A, Trevisan C (1987) MR imaging in a case of Hallervorden-Spatz disease. J Comput Assist Tomogr 11:1057–1058Google Scholar
  41. 41.
    Tennison MB, Bouldin TW, Whaley MD (1988) Mineralization of the basal ganglia detected by CT in Hallervorden-Spatz syndrome. Neurology 38:154–155Google Scholar
  42. 42.
    Vakili S, Drew AL, Von Schunching S, Becker D (1977) Hallervorden-Spatz syndrome. Arch Neurol 34:729–738Google Scholar
  43. 43.
    Van Kirk MP, Larsen PD, O'Conner PS (1986) New computed tomography scan findings in Hallervorden-Spatz syndrome. Clin Neuroophthalmol 6:86–90Google Scholar
  44. 44.
    Walshe JM (1986) Wilson's disease. In: Vinken PJ, Bruyn GW, Klawans HL (eds) Handbook of clinical neurology, vol 49. Elsevier, New York, pp 223–238Google Scholar
  45. 45.
    Wigbolous JM, Bruyn GW (1968) Hallervorden-Spatz disease. In: Vinken PJ, Bruyn GW (eds) Handbook of clinical neurology, vol 6. North-Holland, Amsterdam, pp 604–631Google Scholar

Copyright information

© Springer-Verlag 1992

Authors and Affiliations

  • L. Angelini
    • 1
  • N. Nardocci
    • 1
  • V. Rumi
    • 1
  • C. Zorzi
    • 1
  • L. Strada
    • 2
  • M. Savoiardo
    • 2
  1. 1.Department of Child NeurologyIstituto Nazionale Neurologico “C. Besta”MilanItaly
  2. 2.Department of NeuroradiologyIstituto Nazionale Neurologico “C. Besta”MilanItaly

Personalised recommendations